The Drug Price Transparency in Medicaid Act will protect patients, pharmacies, and others from middlemen tactics that drive up prescription drug prices.
The decision offers hope for the ability of pharmacies to continue to meet patients’ needs in Washington State and across the nation.
Calls on the Center for Medicare and Medicaid Innovation to integrate pharmacies and pharmacists into value-based programs and alternative payment models to accelerate mission toward better outcomes and lower costs.
Pharmacy groups applaud this victory for pharmacies and patient access to care .
The Washington State Pharmacists Association, the National Community Pharmacists Association, and the National Association of Chain Drug Stores today cheered a move by the Department of Justice that could signal victory in their case against unfairly low reimbursements for pharmacies that treat Medicaid patients.
Newly-enacted laws empower pharmacists to focus their time on patients and clinical care, extend Iowans’ access to routine vaccinations and point-of-care testing; Iowa Governor takes action to protect viability of community retail pharmacies throughout the state and the patients they serve.
Pharmacy groups file complaint, urge federal Centers for Medicare & Medicaid Services to reverse the approval of a state plan that unlawfully reimburses pharmacies below the actual cost of dispensing prescriptions to Medicaid patients.
Following the Administrative Law Judge's decision, NACDS, the Washington State Pharmacy Association, and the National Community Pharmacists Association urged the Centers for Medicare & Medicaid Services to bring to an end Washington State’s flawed pharmacy reimbursement plan.
National pharmacy group is highly visible this week at National Association of Medicaid Directors 2020 Virtual Conference; invites Medicaid Directors and staff to interactive booth with flu-communications tools that can help reach vulnerable Americans.
